Zeneca Diprivan Brochure Draws FDA Objection; Lawsuit Information Cited
Executive Summary
Zeneca communications with health care professionals regarding its legal challenge to FDA's approval of GensiaSicor's generic version of Diprivan have drawn an objection from the agency.